Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Arens

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Cell Stem Cell|October 11, 2011
Distinct types of tumor-initiating cells form human colon cancer tumors and metastasesSebastian M Dieter, Claudia R Ball, Christopher M Hoffmann, et al.
Neuroradiology|May 7, 2024
How to evaluate perfusion imaging in post-treatment glioma: a comparison of three different analysis methodsSiem D A Herings, Rik van den Elshout, Rebecca de Wit, et al.
Nature Biotechnology|August 9, 2011
An unbiased genome-wide analysis of zinc-finger nuclease specificityRichard Gabriel, Angelo Lombardo, Anne Arens, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2011
Retroviral gene therapy for X-linked chronic granulomatous disease: results from phase I/II trialHyoung Jin Kang, Cynthia C Bartholomae, Anna Paruzynski, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 3, 2011
Lentiviral vector integration profiles differ in rodent postmitotic tissuesCynthia C Bartholomae, Anne Arens, Kamaljit S Balaggan, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic riskJanka Mátrai, Alessio Cantore, Cynthia C Bartholomae, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 10, 2013
The fetal mouse is a sensitive genotoxicity model that exposes lentiviral-associated mutagenesis resulting in liver oncogenesisAli Nowrouzi, Wing T Cheung, Tingting Li, et al.
The Lancet. Haematology|May 2, 2026
Very early [<sup>18</sup>F]FDG-PET-guided targeted therapy in untreated advanced-stage classic Hodgkin lymphoma (EORTC-1537-COBRA): primary results of a single-arm, multicentre, phase 2 trialMartin Hutchings, Arjan Diepstra, Anna Sureda Balari, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 25, 2011
Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapyAnnette Deichmann, Martijn H Brugman, Cynthia C Bartholomae, et al.
Nature Medicine|December 8, 2009
Comprehensive genomic access to vector integration in clinical gene therapyRichard Gabriel, Ralph Eckenberg, Anna Paruzynski, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cell Stem Cell|October 11, 2011
Distinct types of tumor-initiating cells form human colon cancer tumors and metastasesSebastian M Dieter, Claudia R Ball, Christopher M Hoffmann, et al.
Neuroradiology|May 7, 2024
How to evaluate perfusion imaging in post-treatment glioma: a comparison of three different analysis methodsSiem D A Herings, Rik van den Elshout, Rebecca de Wit, et al.
Nature Biotechnology|August 9, 2011
An unbiased genome-wide analysis of zinc-finger nuclease specificityRichard Gabriel, Angelo Lombardo, Anne Arens, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2011
Retroviral gene therapy for X-linked chronic granulomatous disease: results from phase I/II trialHyoung Jin Kang, Cynthia C Bartholomae, Anna Paruzynski, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 3, 2011
Lentiviral vector integration profiles differ in rodent postmitotic tissuesCynthia C Bartholomae, Anne Arens, Kamaljit S Balaggan, et al.
Hepatology (Baltimore, Md.)|April 27, 2011
Hepatocyte-targeted expression by integrase-defective lentiviral vectors induces antigen-specific tolerance in mice with low genotoxic riskJanka Mátrai, Alessio Cantore, Cynthia C Bartholomae, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 10, 2013
The fetal mouse is a sensitive genotoxicity model that exposes lentiviral-associated mutagenesis resulting in liver oncogenesisAli Nowrouzi, Wing T Cheung, Tingting Li, et al.
The Lancet. Haematology|May 2, 2026
Very early [<sup>18</sup>F]FDG-PET-guided targeted therapy in untreated advanced-stage classic Hodgkin lymphoma (EORTC-1537-COBRA): primary results of a single-arm, multicentre, phase 2 trialMartin Hutchings, Arjan Diepstra, Anna Sureda Balari, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 25, 2011
Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapyAnnette Deichmann, Martijn H Brugman, Cynthia C Bartholomae, et al.
Nature Medicine|December 8, 2009
Comprehensive genomic access to vector integration in clinical gene therapyRichard Gabriel, Ralph Eckenberg, Anna Paruzynski, et al.
Pageof 2